1-4 of 4
Annegret Rosemann
Close
Sort by
Journal Articles

Bone Marrow T Cell Subpopulations in Patients with Newly Diagnosed B-Cell Precursor Acute Lymphoblastic Leukemia (ALL).

Peter Brinkrolf, Silke Landmeier, PhD, Bianca Altvater, PhD, Sibylle Pscherer, Annegret Rosemann, Heribert Juergens, MD, Andreas Ranft, Claudia Rossig, MD
Journal: Blood
Blood (2007) 110 (11): 4278.
https://doi.org/10.1182/blood.V110.11.4278.4278
Published: 2007
Journal Articles

CD34+CD19−, CD34+CD19+ and CD34−CD19+ Cells May All Have Leukemia-Initiating Potential in NOD/ Scid Mice.

Christoph Le Viseur, Marc Hotfilder, PhD, Annegret Rosemann, Ronald Stam, PhD, Andre Schrauder, MD, Leonard Shultz, PhD, Martin Schrappe, MD, Rob Pieters, MD, Josef Vormoor, MD
Journal: Blood
Blood (2006) 108 (11): 2542.
https://doi.org/10.1182/blood.V108.11.2542.2542
Published: 2006
Journal Articles

Aberrant Expression of the Chondroitin Sulfate Proteoglycan NG2 on Pediatric AML/abn(11q23) and ALL/t(4;11) Does Not Allow Flow Cytometric Detection of Leukemic Blasts with a Stem Cell-Like Immunophenotype.

Janna Neudenberger, Marc Hotfilder, PhD, Annegret Rosemann, Claudia Langebrake, Dirk Reinhardt, MD, Josef Vormoor, MD
Journal: Blood
Blood (2004) 104 (11): 4394.
https://doi.org/10.1182/blood.V104.11.4394.4394
Published: 2004
Journal Articles

Immature CD34 + CD19 − progenitor/stem cells in TEL/AML1 -positive acute lymphoblastic leukemia are genetically and functionally normal

Marc Hotfilder, Silja Röttgers, Annegret Rosemann, Heribert Jürgens, Jochen Harbott, Josef Vormoor
Journal: Blood
Blood (2002) 100 (2): 640–646.
https://doi.org/10.1182/blood.V100.2.640
Published: 2002